Revvity (NYSE:RVTY) Price Target Lowered to $125.00 at Robert W. Baird

Revvity (NYSE:RVTY) had its price target trimmed by Robert W. Baird from $127.00 to $125.00 in a research report released on Tuesday,Benzinga reports. The brokerage currently has an outperform rating on the stock.

RVTY has been the topic of several other reports. Wells Fargo & Company decreased their target price on shares of Revvity from $130.00 to $102.00 and set an “equal weight” rating on the stock in a report on Thursday, April 17th. KeyCorp lifted their target price on Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. Raymond James reiterated an “outperform” rating and set a $145.00 price target (up from $140.00) on shares of Revvity in a report on Monday, February 3rd. Barclays reduced their price objective on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Finally, Sanford C. Bernstein lowered shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a research note on Friday, January 10th. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $126.46.

Revvity Trading Down 0.3 %

Shares of Revvity stock opened at $94.75 on Tuesday. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The stock’s 50 day simple moving average is $104.08 and its 200-day simple moving average is $112.67. The stock has a market cap of $11.38 billion, a P/E ratio of 42.87, a P/E/G ratio of 3.82 and a beta of 1.07. Revvity has a 1-year low of $88.53 and a 1-year high of $129.50.

Revvity (NYSE:RVTY) last issued its earnings results on Monday, April 28th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The company had revenue of $664.76 million during the quarter, compared to analysts’ expectations of $662.30 million. During the same period in the prior year, the business earned $0.98 EPS. The firm’s quarterly revenue was up 2.3% on a year-over-year basis. Analysts predict that Revvity will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.30%. The ex-dividend date is Friday, July 18th. Revvity’s dividend payout ratio is presently 12.67%.

Insider Activity at Revvity

In other Revvity news, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the sale, the insider now directly owns 33,400 shares of the company’s stock, valued at $4,232,782. The trade was a 31.23 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.68% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Revvity

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Tidal Investments LLC lifted its position in Revvity by 2,388.8% in the third quarter. Tidal Investments LLC now owns 52,787 shares of the company’s stock valued at $6,744,000 after acquiring an additional 50,666 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Revvity by 3.1% in the 3rd quarter. Principal Financial Group Inc. now owns 141,871 shares of the company’s stock valued at $18,124,000 after purchasing an additional 4,263 shares during the last quarter. JPMorgan Chase & Co. boosted its position in shares of Revvity by 13.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 344,115 shares of the company’s stock valued at $43,961,000 after purchasing an additional 41,497 shares during the period. GAMMA Investing LLC grew its stake in Revvity by 10.8% during the 4th quarter. GAMMA Investing LLC now owns 1,898 shares of the company’s stock worth $212,000 after buying an additional 185 shares during the last quarter. Finally, Nordea Investment Management AB increased its position in Revvity by 8.0% during the fourth quarter. Nordea Investment Management AB now owns 9,681 shares of the company’s stock worth $1,084,000 after buying an additional 719 shares during the period. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.